Crestline Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-34,887
Closed -$2.91M 177
2023
Q4
$2.91M Buy
34,887
+14,887
+74% +$1.24M 0.25% 111
2023
Q3
$589K Buy
+20,000
New +$589K 0.07% 134